This bill mandates the Board of Pharmacy in Minnesota to adopt new rules regarding prescription drug labeling. Specifically, it requires the amendment of Minnesota Rules, part 6800.3400, to allow for the inclusion of the complete and unabbreviated generic name of the drug on prescription labels, as well as instructions written in plain language that explain the patient-specific indications for the drug. The Board of Pharmacy is also required to follow the procedures outlined in Minnesota Statutes, section 14.389, when implementing these amendments.

The bill includes a provision stating that the new rules will take effect the day after the bill is enacted. This initiative aims to enhance the clarity and comprehensibility of prescription labels, ultimately improving patient understanding and safety regarding their medications.

Statutes affected:
Introduction: 151.01